Aktieanalys

IRLAB: IRL757 phase I ready and receives financing from the Michael J. Fox Foundation - Redeye

{newsItem.title}

Redeye Publicerad: 22 Dec 2023 07:25

IRLAB Therapeutics

Redeye comments on the news that IRL757 is phase I ready and that IRLAB receives financing from the Michael J. Fox Foundation to fund the trial.

Länk till analysen i sin helhet: https://www.redeye.se/research/968343/irlab-irl757-phase-i-ready-and-receives-financing-from-the-michael-j-fox-foundation?utm_source=finwire&utm_medium=RSS

Nyheter om IRLAB Therapeutics

Läses av andra just nu

Om aktien IRLAB Therapeutics

Senaste nytt